Increased vanilloid receptor VR1 innervation in vulvodynia

被引:118
|
作者
Tympanidis, P
Casula, MA
Yiangou, Y
Terenghi, G
Dowd, P
Anand, P
机构
[1] Hammersmith Hosp, Imperial Coll, Sch Med, Peripheral Neuropathy Unit, London W12 0NN, England
[2] UCL Hosp Trust, Dept Dermatol, London, England
[3] Royal Free & UCL, Sch Med, Blond McIndoe Ctr, London, England
关键词
vanilloid receptor VR1; TRPV1; vulvodynia; pain; voltage-gated sodium channel SNS/PN3; Nav1.8;
D O I
10.1016/S1090-3801(03)00085-5
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Vulvodynia is characterised by painful burning sensation, allodynia and hyperalgesia, in the region of the vulval vestibulus. While in many patients the cause of vulvodynia remains uncertain, we and others have previously shown increased intraepithelial and papillary innervation in vulvodynia. The vanilloid receptor VR1 (TRPV1) is expressed by nociceptors, and is triggered by capsaicin, noxious heat, protons, and chemicals produced during inflammation. In the present study we show increased papillary VR1 fibres by immunostaining and image analysis in vulvodynia tissues compared to controls (P < 0.002). VR1 expression was found to be significantly increased when the percentage area immunostained was expressed as a ratio of VR1 to PGP 9.5, a pan-neuronal marker (P = 0.01). VR1-positive fine epidermal fibres also appeared to be increased in vulvodynia tissues, by inspection. Fibres immunoreactive to the voltage-gated sodium channel SNS1/PN3 (Nav1.8), also expressed by nociceptors, were relatively scarce in both vulvodynia and control tissues. We hypothesize that increased expression of VR1 by nociceptors could mediate some of the symptoms in vulvodynia, for which systemic or topical specific VR1 antagonists may provide novel treatment. (C) 2003 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
  • [1] Activation of vanilloid receptor 1 (VR1) by eugenol
    Yang, BH
    Piao, ZG
    Kim, YB
    Lee, CH
    Lee, JK
    Park, K
    Kim, JS
    Oh, SB
    [J]. JOURNAL OF DENTAL RESEARCH, 2003, 82 (10) : 781 - 785
  • [2] Role of vanilloid receptor 1 (VR1) in increased nociceptive signaling in experimental pancreatitis
    Zou, L
    Shenoy, M
    Winston, JH
    Pasricha, PJ
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A179 - A179
  • [3] Ethanol modulation of Vanilloid (VR1) receptor.
    Johnson, WD
    Onaivi, ES
    Taylor, RE
    Akinshola, BE
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 144A - 144A
  • [4] Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract
    Ward, SM
    Bayguinov, J
    Won, KJ
    Grundy, D
    Berthoud, HR
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2003, 465 (01) : 121 - 135
  • [5] Gingerols: a novel class of vanilloid receptor (VR1) agonists
    Dedov, VN
    Tran, VH
    Duke, CC
    Connor, M
    Christie, MJ
    Mandadi, S
    Roufogalis, BD
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (06) : 793 - 798
  • [6] Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat
    Tóth, A
    Kedei, N
    Wang, Y
    Blumberg, PM
    [J]. LIFE SCIENCES, 2003, 73 (04) : 487 - 498
  • [7] Identification of a functional vanilloid receptor (VR1) in human keratinocytes
    Nicol, GD
    Li, T
    Gharibova, LS
    Pei, Y
    Travers, JB
    Southall, MD
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 315 - 315
  • [8] The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat
    Sanchez, JF
    Krause, JE
    Cortright, DN
    [J]. NEUROSCIENCE, 2001, 107 (03) : 373 - 381
  • [9] Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection
    Pegorini, S
    Zani, A
    Braida, D
    Guerini-Rocco, C
    Sala, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 (05) : 552 - 559
  • [10] Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology
    Smart, D
    Jerman, JC
    Gunthorpe, MJ
    Brough, SJ
    Ranson, J
    Cairns, W
    Hayes, PD
    Randall, AD
    Davis, JB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 417 (1-2) : 51 - 58